- Cusumano LR , Tran V , Tlamsa A , et al. Rapidly growing Mycobacterium infections after cosmetic surgery in medical tourists: The Bronx experience and a review of the literature. Int J Infect Dis . 2017; 63:1–6. doi:10.1016/j.ijid.2017.07.022.
- Wallace RJ, Jr , Brown BA , Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis . 1992;166(2):405–412. doi:10.1093/infdis/166.2.405.
- Kaushik A , Ammerman N , Martins O , Parrish N , Nuermberger E. In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus . Antimicrob Agents Chemother . 2019;63(6):e00470. doi:10.1128/AAC.00470-19.
- Shoen C , Benaroch D , Sklaney M , Cynamon M. In vitro activities of omadacycline against rapidly growing mycobacteria. Antimicrob Agents Chemother . 2019;63(5):e0252. doi:10.1128/AAC.02522-18.
- O'Riordan W , Cardenas C , Shin E , et al. Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial. Lancet Infect Dis . 2019;19(10):1080–1090. doi:10.1016/S1473-3099(19)30275-0.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 4
Case Studies
Omadacycline for treatment of Mycobacterium chelonae skin infection
Madeline Frizzella Texas A&M College of Medicine, Bryan, TexasCorrespondence[email protected]
https://orcid.org/0000-0003-3463-4944
, MShttps://orcid.org/0000-0003-3463-4944, , MD & Karen Brustc Department of Infectious Diseases, Baylor Scott and White Medical Center – Temple, Temple, Texashttps://orcid.org/0000-0001-5853-2323
, MDhttps://orcid.org/0000-0001-5853-2323